Back to top
more

Health Catalyst (HCAT)

(Delayed Data from NSDQ)

$1.60 USD

1.60
207,298

+0.01 (0.31%)

Updated Aug 28, 2026 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 248)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Elevance Health (ELV) Bolsters CarelonRx With Paragon Buyout

by Zacks Equity Research

The infusion services from Paragon Healthcare are expected to complement Elevance Health's (ELV) suite of pharmacy services.

Zacks Equity Research

An In-Depth Analysis of Encompass Health's (EHC) 2024 Outlook

by Zacks Equity Research

Growth in Medicare and Managed Care pricing, along with capacity additions of six de novos with 280 beds, will likely have an impact on Encompass Health's (EHC) 2024 bottom line.

Zacks Equity Research

The Joint (JYNT) Rises 30% as Q4 Earnings Beat on Higher Clinics

by Zacks Equity Research

The Joint (JYNT) expects 2024 system-wide sales to be within $530-$545 million.

Zacks Equity Research

Ensign Group (ENSG) Up 30.8% in 6 Months: More Growth Ahead?

by Zacks Equity Research

Ensign Group's (ENSG) growing strength in its Skilled Services business is a major upside.

Zacks Equity Research

HCA Healthcare (HCA) Rises 24.8% in a Year: More Room to Run?

by Zacks Equity Research

HCA Healthcare's (HCA) growing equivalent admissions are supporting performance.

Zacks Equity Research

After Plunging -24.47% in 4 Weeks, Here's Why the Trend Might Reverse for Health Catalyst (HCAT)

by Zacks Equity Research

The heavy selling pressure might have exhausted for Health Catalyst (HCAT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks Equity Research

Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics

by Zacks Equity Research

Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Health Catalyst (HCAT) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Health Catalyst (HCAT) delivered earnings and revenue surprises of 300% and 1.92%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Health Catalyst (HCAT) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for Health Catalyst (HCAT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Zacks Equity Research

Insulet (PODD) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Insulet (PODD) is expected to have benefited from the ongoing rollout of Omnipod 5 in several international markets in the fourth quarter.